NOV Inc (NOV) Misses Q1 EPS by 6c

NOV Inc (NYSE: NOV) reported Q1 EPS of $0.19, $0.06 worse than the analyst estimate of $0.25. Revenue for the quarter came in at $2.1 billion versus the consensus estimate of $2.1 billion.

Guidance:

Q2 2025 Outlook

The Company is providing financial guidance for the second quarter of 2025, which constitutes “forward-looking statements” as described further below under “Cautionary Note Regarding Forward-Looking Statements.”

For the second quarter of 2025 management expects year-over-year consolidated revenues to be down one to four percent with Adjusted EBITDA between $250 million and $280 million.

For earnings history and earnings-related data on NOV Inc (NOV) click here.

You May Also Be Interested In

• Ultragenyx Pharma (RARE) Misses Q3 EPS by 6c; Offers Guidance
• Navigator Holdings Ltd. (NVGS) Misses Q3 EPS by 14c
• Sixth Street Specialty Lending (TSLX) Reports In-Line Q3 EPS